Tous les communiqués | WebDisclosure

Switch to English

9557	Sociétés
188785	Mots-clés
120541	Articles
100763	Communiqués

Accueil
Tous les communiqués

COMMUNIQUÉ DE PRESSE

publié le 13/06/2025 à 00:30, il y a 6 mois 6 jours

Grande Portage Closes Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Grande Portage closes non-brokered private placement of 22,500,000 Units at $0.20 per Unit for gross proceeds of $4,500,000. Offering under National Instrument 45-106, aims for exploration and development of New Amalga Gold project

Private Placement Exploration Units Grande Portage New Amalga Gold Project
COMMUNIQUÉ DE PRESSE

publié le 12/06/2025 à 23:30, il y a 6 mois 6 jours

Cypher Provides Fourth Default Status Update
Cypher Metaverse Inc. provides update on default status report under NP 12-203, addressing delays in financial filings & commitments to meet obligations

Cypher Metaverse Inc. Financial Filings NP 12-203 Management Cease Trade Orders Interim Filings
COMMUNIQUÉ DE PRESSE

publié le 12/06/2025 à 23:15, il y a 6 mois 6 jours

Slam Raises $350,000 in Flow-Through Private Placement, Resignation of a Director and Appointment of a New Director and Appointment of Vice President
SLAM Exploration Ltd. closes non-brokered flow-through private placement, issues 10M FT Units at $0.035 for $350K. Board changes and insider participation announced

Private Placement Board Changes Insider Participation FT Units SLAM Exploration Ltd.
COMMUNIQUÉ DE PRESSE

publié le 12/06/2025 à 22:42, il y a 6 mois 6 jours

Informations privilégiées / Autres communiqués
GeNeuro annonce l’ouverture de la procédure de redressement judiciaire de sa filiale GeNeuro Innovation SAS. La société cherche à se restructurer pour surmonter ses difficultés financières

Restructuration Difficultés Financières Redressement Judiciaire GeNeuro Sursis Concordataire
COMMUNIQUÉ DE PRESSE

publié le 12/06/2025 à 22:42, il y a 6 mois 6 jours

Inside Information / Other news releases
GeNeuro SA's French subsidiary GeNeuro Innovation SAS enters receivership proceedings amidst parent company's debt-restructuring efforts

Autoimmune Diseases GeNeuro SA Neurodegenerative Diseases Debt-restructuring Receivership Proceedings
COMMUNIQUÉ DE PRESSE

publié le 12/06/2025 à 22:05, il y a 6 mois 6 jours

DBV Technologies participera au prochain congrès EAACI 2025
DBV Technologies participera au congrès EAACI 2025 à Glasgow pour présenter des avancées scientifiques sur l'immunothérapie épicutanée dans les allergies alimentaires

DBV Technologies Allergies Alimentaires Immunothérapie Épicutanée Congrès EAACI 2025 Avancées Scientifiques
COMMUNIQUÉ DE PRESSE

publié le 12/06/2025 à 22:05, il y a 6 mois 6 jours

DBV Technologies to Participate in Upcoming EAACI Congress 2025
DBV Technologies to participate in the upcoming EAACI Congress 2025, presenting data on peanut patch and cow's milk allergy diagnosis. Symposium on epicutaneous immunotherapy and clinical relationships

DBV Technologies Food Allergies Epicutaneous Immunotherapy Peanut Allergy EAACI Congress
COMMUNIQUÉ DE PRESSE

publié le 12/06/2025 à 21:20, il y a 6 mois 6 jours

D. Boral Capital Acted as Sole Bookrunner to Aduro Clean Technologies (Nasdaq: ADUR) in connection with its $8.0 Million Follow-On Offering
Aduro Clean Technologies closes successful underwritten U.S. public offering of common shares and warrants. Proceeds for R&D and plant construction

Common Shares Clean Technology Public Offering Underwritten Aduro Clean Technologies
COMMUNIQUÉ DE PRESSE

publié le 12/06/2025 à 20:55, il y a 6 mois 6 jours

Amaze Announces Annual Stockholders' Meeting Results and 1-for-23 Reverse Stock Split
Amaze Holdings, Inc. announces results of annual stockholders' meeting, including approved proposals and a reverse stock split. Visit www.amaze.co for more info

Financial Results Reverse Stock Split Annual Meeting Stockholders Amaze Holdings Inc.
COMMUNIQUÉ DE PRESSE

publié le 12/06/2025 à 19:16, il y a 6 mois 6 jours

GTT: Main terms and conditions of the share buy-back programme
GTT announces share buy-back programme with maximum purchase price of €190 per share and total authorized amount of €705,237,630 until December 10, 2026

Share Buy-back Treasury Shares AMF Regulations GTT Maximum Purchase Price

Les Echos

Publié le 19/12/2025 à 08:30, il y a 10 heures 10 minutes

Share capital decrease by way of treasury shares cancellation
Publié le 19/12/2025 à 08:30, il y a 10 heures 10 minutes

Réduction du capital par voie d’annulation d’actions propres
Publié le 19/12/2025 à 07:00, il y a 11 heures 40 minutes

EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Publié le 19/12/2025 à 07:00, il y a 11 heures 40 minutes

EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
Publié le 18/12/2025 à 18:30, il y a 1 jour

Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 19/12/2025 à 18:30, il y a 10 minutes

Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Publié le 19/12/2025 à 14:40, il y a 4 heures

Northern Superior Announces Closing of the Arrangement
Publié le 19/12/2025 à 13:30, il y a 5 heures 10 minutes

Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Publié le 19/12/2025 à 13:30, il y a 5 heures 10 minutes

DataMetrex Announces Closing of Yuzu Payment Processing Solution Acquisition
Publié le 19/12/2025 à 13:30, il y a 5 heures 10 minutes

Sterling Metals Provides Year End Update to Stakeholders

Voir tout ACCESSWIRE

EQS Group

Publié le 19/12/2025 à 18:29, il y a 11 minutes

clearvise AG commissions Triticum agri-photovoltaic project
Publié le 19/12/2025 à 18:29, il y a 11 minutes

Fuller, Smith & Turner PLC: Transaction in own shares
Publié le 19/12/2025 à 18:27, il y a 13 minutes

Resumed Trading in the Bond
Publié le 19/12/2025 à 18:19, il y a 21 minutes

POS-Transaction in Own Shares
Publié le 19/12/2025 à 17:56, il y a 43 minutes

Affluent Medical annonce l’acquisition prochaine de Caranx Medical et Artedrone et devient Carvolix, pionnier des thérapies cardiovasculaires.